By Professor Nada Hamad

Journal articles

Minson A; Hamad N; Butler JP; Westerman DA; Ritchie D; Blombery P; Seymour JF; Tam CS; Dickinson M, 2020, 'A Phase II, Open-Label, Single Arm Trial to Assess the Efficacy and Safety of the Combination of Tisagenlecleucel and Ibrutinib in Mantle Cell Lymphoma (TARMAC)', Blood, 136, pp. 34 - 35, http://dx.doi.org/10.1182/blood-2020-138946

Moore J; Kwan J; Gottlieb D; Bajel A; Ritchie D; Yeung DT; Greenwood M; Purtill D; Tran S; Aarons D; Hamad N, 2020, 'A Prospective Haploidentical Peripheral Blood Stem Cell Transplant Study Using a Pre-Defined Conditioning Regimen Intensity Based on Age and the Hematopoietic Cell Transplantation Comorbidity Index- Anzhit 1: Encouraging Preliminary Survival Outcomes at One Year Follow up', Blood, 136, pp. 51 - 52, http://dx.doi.org/10.1182/blood-2020-142131

Cashman H; Mayson E; Kliman D; Vachalec S; Bell J; Milliken S; Moore J; Lavee O; Withers B; Hamad N, 2020, 'A Shared Electronic Health Record in a Rural Setting Maintains Hematological Cancer Services Remotely during the COVID-19 Pandemic', Blood, 136, pp. 5 - 5, http://dx.doi.org/10.1182/blood-2020-142209

Boyle S; Tobin JWD; Perram J; Hamad N; Barraclough A; Singaraveloo L; Han M-H; Blennerhassett R; Nelson NE; Johnston A; Talaulikar D; Karpe K; Bhattacharyya A; Cheah CY; Subramoniapillai E; Bokhari W; Lee C; Hawkes EA; Gullapalli V; Jabbour A; Strasser S; Chadban S; Brown C; Mollee P; Hapgood G, 2020, 'Management and Outcomes of Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder in the PET/CT Era: A Multicentre Study from the Australasian Lymphoma Alliance', Blood, 136, pp. 36 - 38, http://dx.doi.org/10.1182/blood-2020-140665

White J; Hamad N; Linn SM; Novitzky-Basso IN; Abduljalil O; Law A; Kim DDH, 2020, 'Multicenter, Retrospective Evaluation of Therapeutic Efficacy of Ruxolitinib for Chronic Gvhd Treatment', Blood, 136, pp. 45 - 47, http://dx.doi.org/10.1182/blood-2020-136164

Benajiba L; Carraway HE; Hamad N; Stein EM; Yannakou CK; Burroughs A; Harris S; Lane H; Nguyen DD; Stuart M; Vargas J; Puissant A; Stegmaier K; DiNardo CD, 2020, 'Trials in Progress: A Phase I Study to Evaluate the Safety and Pharmacokinetic Profiles of CB-5339 in Participants with Relapsed/Refractory Acute Myeloid Leukemia or Relapsed/Refractory Intermediate or High-Risk Myelodysplastic Syndrome', Blood, 136, pp. 21, http://dx.doi.org/10.1182/blood-2020-140636

Paterson JA; Hwang A; Wong S; Sewell W; Joseph JE; Hamad N, 2020, 'Two Rare Cases of Severe Autoimmune Dyserythropoiesis without Any Underlying Haematological Malignancy or Autoimmune Disease', Blood, 136, pp. 2 - 3, http://dx.doi.org/10.1182/blood-2020-142281

Othman J; Greenwood M; Moore J; Larsen S; Watson AM; Arthur C; Bhattacharyya A; Bilmon I; Blyth E; Bryant A; Bryant C; Dunlop L; Fay K; Gibson J; Hamad N; Kerridge I; Kwan J; Ma D; Micklethwaite K; Milliken S; Panicker S; Stevenson W; Withers B; Wilcox L; Tran S; Gottlieb DJ, 2020, 'Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATG', Biology of Blood and Marrow Transplantation, 26, pp. 1868 - 1875, http://dx.doi.org/10.1016/j.bbmt.2020.06.030

Purtill D; Antonenas V; Chiappini P; Tong D; O’Flaherty E; Bajel A; Kabani K; Larsen S; Tan S; Hutchins C; Curtis DJ; Kennedy GA; Watson AM; Bai LJ; Greenwood M; Gottlieb DJ; Hamad N, 2020, 'Variable CD341 recovery of cryopreserved allogeneic HPC products: Transplant implications during the COVID-19 pandemic', Blood Advances, 4, pp. 4147 - 4150, http://dx.doi.org/10.1182/bloodadvances.2020002431

Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D, 2020, 'Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation', Biology of Blood and Marrow Transplantation, 26, pp. 1711 - 1718, http://dx.doi.org/10.1016/j.bbmt.2020.03.005

Kalakonda N; Maerevoet M; Cavallo F; Follows G; Goy A; Vermaat JSP; Casasnovas O; Hamad N; Zijlstra JM; Bakhshi S; Bouabdallah R; Choquet S; Gurion R; Hill B; Jaeger U; Manuel Sancho J; Schuster M; Thieblemont C; De la Cruz F; Egyed M; Mishra S; Offner F; Vassilakopoulos TP; Warzocha K; McCarthy D; Ma X; Corona K; Saint-Martin J-R; Chang H; Landesman Y; Joshi A; Wang H; Shah J; Shacham S; Kauffman M; Van den Neste E; Canales MA, 2020, 'Selinexor in patients with relapsed or refractory diffuse large B -cell lymphoma (SADAL): a single -arm, multinational, multicentre, open -label, phase 2 trial', LANCET HAEMATOLOGY, 7, pp. E509 - E522, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000544758900006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kalakonda N; Maerevoet M; Cavallo F; Follows G; Goy A; Vermaat JSP; Casasnovas O; Hamad N; Zijlstra JM; Bakhshi S; Bouabdallah R; Choquet S; Gurion R; Hill B; Jaeger U; Sancho JM; Schuster M; Thieblemont C; De la Cruz F; Egyed M; Mishra S; Offner F; Vassilakopoulos TP; Warzocha K; McCarthy D; Ma X; Corona K; Saint-Martin JR; Chang H; Landesman Y; Joshi A; Wang H; Shah J; Shacham S; Kauffman M; Van Den Neste E; Canales MA, 2020, 'Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial', Lancet Haematology, 7, pp. e511 - e522, http://dx.doi.org/10.1016/S2352-3026(20)30120-4

Di Ciaccio P; McCaughan G; Trotman J; Ho PJ; Cheah CY; Gangatharan S; Wight J; Ku M; Quach H; Gasiorowski R; Polizzotto MN; Prince HM; Mulligan S; Tam CS; Gregory G; Hapgood G; Spencer A; Dickinson M; Latimer M; Johnston A; Armytage T; Lee C; Cochrane T; Berkhahn L; Weinkove R; Doocey R; Harrison SJ; Webber N; Lee HP; Chapman S; Campbell BA; Gibbs SDJ; Hamad N, 2020, 'Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic', Internal Medicine Journal, 50, pp. 667 - 679, http://dx.doi.org/10.1111/imj.14859

Hamad N; Gottlieb D; Ritchie D; Kennedy G; Watson AM; Greenwood M; Doocey R; Perera T; Spencer A; Wong E; O'Brien T; Shaw P; Conyers R; Cole T; Milliken S; Bardy P; Larsen S; Lai H; Butler A; Fraser C; Bajel A; Butler J; Kerridge I; Purtill D, 2020, 'Bone Marrow Transplant Society of Australia and New Zealand COVID-19 consensus position statement', Internal Medicine Journal, 50, pp. 774 - 775, http://dx.doi.org/10.1111/imj.14867

Casasnovas RO; Daniele P; Tremblay G; Maerevoet M; Zijlstra J; Follows G; Vermaat JSP; Kalakonda N; Goy AH; Choquet S; Van Den Neste E; Hill BT; Thieblemont C; Cavallo F; de la Cruz F; Kuruvilla J; Hamad N; Bouabdallah R; Jäger U; Caimi P; Gurion R; Warzocha K; Bakhshi S; Sancho JM; Schuster M; Egyed M; Offner F; Vasilakopoulos T; Samal P; Nagy A; Ku M; Albendea MÁC, 2020, 'PCN325 Health Utility in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR-DLBCL) Patients - Results of a Phase II Trial with ORAL Selinexor', Value in Health, 23, pp. s479 - s480, http://dx.doi.org/10.1016/j.jval.2020.08.462

Gerstl B; Sullivan E; Koch J; Wand H; Ives A; Mitchell R; Hamad N; Anazodo A, 2019, 'Reproductive outcomes following a stem cell transplant for a haematological malignancy in female cancer survivors: a systematic review and meta-analysis', Supportive Care in Cancer, 27, pp. 4451 - 4460, http://dx.doi.org/10.1007/s00520-019-05020-8

Lwin Y; He SZ-X; Spencer A; Purtill D; Mcewan A; Browett P; Butler A; Carter J; Bardy PG; Kennedy GA; Szer J; Ritchie D; Greenwood M; Larsen SR; Milliken S; Lai HC; Gottlieb D; Kwan J; Aarons D; Tran S; Hamad N, 2019, 'An Update of Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era', BLOOD, 134, http://dx.doi.org/10.1182/blood-2019-126547

Park JH; Woo YM; Youm EM; Hamad N; Won HH; Naka K; Park EJ; Park JH; Kim HJ; Kim SH; Kim HJ; Ahn JS; Sohn SK; Moon JH; Jung CW; Park S; Lipton JH; Kimura S; Kim JW; Kim DH, 2019, 'HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia', Leukemia, 33, pp. 1439 - 1450, http://dx.doi.org/10.1038/s41375-018-0321-8

McCarthy R-L; McNamee N; Copelin B; Mills G; Wong S; Qiu MR; Earls P; Milliken S; Hamad N; Fay K; Lukeis R; Parker A; Moore J, 2019, 'A case series of langerhans cell histiocytosis with braf testing', Pathology, 51, pp. s92, http://dx.doi.org/10.1016/j.pathol.2018.12.243

Lewis KL; Dowling M; Bavishi K; Øvlisen AK; Hamad N; Choi P; Grigg A; P'Ng S; Filshie R; Ritchie DS; Bilmon I; Prince HM; Wolf M; Hertzberg M; Chuah H; El‐Galaly TC; Tam CS; Seymour JF; Cheah CY, 2019, 'CLINICAL OUTCOMES FROM VENETOCLAX BASED THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMAS', Hematological Oncology, 37, pp. 535 - 537, http://dx.doi.org/10.1002/hon.221_2631

Poch Martell M; Hamad N; Shin E; Moon JH; Sohn SK; Uhm J; Michelis FV; Viswabandya A; Lipton JH; Messner HA; Kim DDH, 2017, 'Distinctive clinical characteristics and favorable outcomes in patients with large granular lymphocytosis after allo-HCT: 12-year follow-up data', European Journal of Haematology, 99, pp. 160 - 168, http://dx.doi.org/10.1111/ejh.12899

Moon JH; Hamad N; Sohn SK; Uhm J; Alam N; Gupta V; Lipton JH; Messner HA; Seftel M; Kuruvilla J; Kim DH, 2017, 'Improved prognostic stratification power of CIBMTR risk score with the addition of absolute lymphocyte and eosinophil counts at the onset of chronic GVHD', Annals of Hematology, 96, pp. 805 - 815, http://dx.doi.org/10.1007/s00277-017-2939-4

Zheng Q; Cao J; Hamad N; Kim HJ; Moon JH; Sohn SK; Jung CW; Lipton JH; Kim DDH, 2016, 'Single nucleotide polymorphisms in apoptosis pathway are associated with response to imatinib therapy in chronic myeloid leukemia', Journal of Translational Medicine, 14, pp. 82, http://dx.doi.org/10.1186/s12967-016-0837-5

Hamad N; Armytage T; McIlroy K; Singh N; Ward C, 2015, 'Primary cutaneous mantle-cell lymphoma: A case report and literature review', Journal of Clinical Oncology, 33, pp. e104 - e108, http://dx.doi.org/10.1200/JCO.2012.47.2829

Hamad N; Shanavas M; Michelis FV; Uhm J; Gupta V; Seftel M; Kuruvilla J; Lipton JH; Messner HA; Kim DDH, 2015, 'Mycophenolate-based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative-related donor stem cell transplantation', American Journal of Hematology, 90, pp. 392 - 399, http://dx.doi.org/10.1002/ajh.23955

Hamad N; Kliman D; Best OG; Caramins M; Hertzberg M; Lindeman R; Porter R; Mulligan SP, 2015, 'Chronic lymphocytic leukaemia, monoclonal B-lymphocytosis and pregnancy: Five cases, a literature review and discussion of management', British Journal of Haematology, 168, pp. 350 - 360, http://dx.doi.org/10.1111/bjh.13134

Al-Daraiseh AA; Al Omari D; Al Hamid H; Hamad N; Althemali R, 2015, 'Effectiveness of Iphone's Touch ID: KSA Case Study', INTERNATIONAL JOURNAL OF ADVANCED COMPUTER SCIENCE AND APPLICATIONS, 6, pp. 154 - 161, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000357578700022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Uhm J; Hamad N; Shin EM; Michelis FV; Shanavas M; Gupta V; Kuruvilla J; Lipton JH; Messner HA; Seftel M; Kim DDH, 2014, 'Incidence, risk factors, and long-term outcomes of sclerotic graft-versus-host disease after allogeneic hematopoietic cell transplantation', Biology of Blood and Marrow Transplantation, 20, pp. 1751 - 1757, http://dx.doi.org/10.1016/j.bbmt.2014.07.001

Hamad N; Del Bel R; Messner HA; Kim D; Kuruvilla J; Lipton JH; Uhm J; Seftel M; Alam N; Xu W; Gupta V, 2014, 'Outcomes of Hematopoietic Cell Transplantation in Adult Patients with Acquired Aplastic Anemia Using Intermediate-Dose Alemtuzumab-Based Conditioning', Biology of Blood and Marrow Transplantation, 20, pp. 1722 - 1728, http://dx.doi.org/10.1016/j.bbmt.2014.06.033

Kim D; Hamad N; Lee HG; Kamel-Reid S; Lipton JH, 2014, 'BCR/ABL level at 6 months identifies good risk CML subgroup after failing early molecular response at 3 months following imatinib therapy for CML in chronic phase', American Journal of Hematology, 89, pp. 626 - 632, http://dx.doi.org/10.1002/ajh.23707

Kim D; Won HH; Su S; Cheng L; Xu W; Hamad N; Uhm J; Gupta V; Kuruvilla J; Messner HA; Lipton JH, 2014, 'Risk stratification of organ-specific GVHD can be improved by single-nucleotide polymorphism-based risk models', Bone Marrow Transplantation, 49, pp. 649 - 656, http://dx.doi.org/10.1038/bmt.2014.20

Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D, 2014, 'Validation of national institutes of health global scoring system for chronic Graft-Versus-Host Disease (GVHD) according to overall and GVHD-specific survival', Biology of Blood and Marrow Transplantation, 20, pp. 556 - 563, http://dx.doi.org/10.1016/j.bbmt.2014.01.010

Hamad N; Kliman D; Best OG; Caramins M; Hertzberg M; Lindeman R; Porter R; Mulligan SP, 2014, 'Chronic lymphocytic leukaemia, monoclonal B-lymphocytosis and pregnancy: Five cases, a literature review and discussion of management', British Journal of Haematology, http://dx.doi.org/10.1111/bjh.13134

Shanavas M; Hamad N; Michelis FV; Uhm J; Gupta V; Kuruvilla J; Messner HA; Lipton JH; Kim DDH, 2013, 'Risk Factors For Chronic Eye and Mouth GVHD In Unrelated Hematopoietic Cell Transplantation: T Cell Depletion Is The Only Risk Factor Identified and Appears To Be Favorable', Blood, 122, pp. 4601, http://dx.doi.org/10.1182/blood.v122.21.4601.4601

Conference Papers

Garderet L; Gras L; Koster L; D'Souza A; Estrada-Merly N; Hari P; Saber W; Cowan AJ; Iida M; Okamoto S; Takamatsu H; Mizuno S; Kawamura K; Kodera Y; Hamad N; Ko B-S; Liam C; Ho KW; Goh AS; Tan SK; Elhaddad AM; Bazarbachi A; Chaudhry QUN; Alfar R; Bekadja M-A; Benakli M; Ortiz CAF; Riva E; Galeano S; Bass F; Mian HS; McCurdy A; Wang FR; Neumann D; Koh M; Snowden JA; Schönland S; McLornan DP; Hayden PJ; Sureda A; Greinix HT; Aljurf M; Atsuta Y; Niederwieser D, 2022, 'International Differences in Baseline Characteristics and Practice Patterns in Patients with NEWLY Diagnosed Multiple Myeloma Undergoing Upfront Autologous STEM Cell Transplantation', in Blood, American Society of Hematology, pp. 5225 - 5227, http://dx.doi.org/10.1182/blood-2022-165010

Garderet L; Gras L; Koster L; D'Souza A; Estrada-Merly N; Hari P; Saber W; Cowan AJ; Iida M; Okamoto S; Takamatsu H; Mizuno S; Kawamura K; Kodera Y; Hamad N; Ko B-S; Liam C; HO KW; Goh AS; Tan SK; Elhaddad AM; Bazarbachi A; Chaudhry QUN; Alfar R; Bekadja M-A; Benakli M; Ortiz CAF; Riva E; Galeano S; Bass F; Mian HS; McCurdy A; Wang FR; Neumann D; Koh M; Snowden JA; Schönland S; McLornan DP; Hayden PJ; Sureda A; Greinix HT; Aljurf M; Atsuta Y; Niederwieser D, 2022, 'Worldwide Network for Blood and Marrow Transplantation (WBMT) Global Study on Baseline Characteristics and Clinical Outcomes in NEWLY Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous STEM Cell Transplantation, a Study Off 61,725 Patients from 629 Centers', in Blood, American Society of Hematology, pp. 4839 - 4842, http://dx.doi.org/10.1182/blood-2022-164619

Mickinso M; Hamad N; Bryant CE; Borthakur G; Hosing C; Shook D; Tan J; Rajangam K; Liu H; Kennedy GA; McSweeney PA; Hill BT, 2021, 'A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects with B-Cell Malignancies', in BLOOD, ELSEVIER, GA, Atlanta, pp. 3868 - +, presented at 63rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), GA, Atlanta, 11 December 2021 - 14 December 2021, http://dx.doi.org/10.1182/blood-2021-146602Get

Di Ciaccio PR; Greenwood M; Kennedy GA; Milliken S; Gottlieb D; Ritchie D; Purtill D; Larsen SR; Spencer A; Perera T; Yeung DT; Durrant S; Butler A; Watson A-M; Lai HC; Doocey R; Goodman HJ; Kerridge IH; Arthur C; Curley C; Stewart C; Micklethwaite KP; Collins J; Cooney J; Hamad N, 2020, 'Allogeneic Stem Cell Transplantation for Diffuse Large B Cell Lymphoma Can Achieve Durable Remissions: An Australasian Bone Marrow Transplant Recipient Registry Study', in BLOOD, ELSEVIER, ELECTR NETWORK, presented at 62nd Annual Meeting of the American-Society-of-Hematology (ASH), ELECTR NETWORK, 05 December 2020 - 08 December 2020, http://dx.doi.org/10.1182/blood-2020-139076

Di Ciaccio PR; Ritchie D; Kennedy GA; Milliken S; Purtill D; Gottlieb D; Perera T; Yeung DT; Larsen SR; Doocey R; Greenwood M; Durrant S; Watson A-M; Butler A; Khot A; Curley C; Hamad N, 2020, 'Allogeneic Stem Cell Transplantation for Mantle Cell Lymphoma Can Achieve Durable Remission and Myeloablative Conditioning Is Associated with Inferior Survival: An Australasian Bone Marrow Transplant Recipient Registry Study', in BLOOD, ELSEVIER, ELECTR NETWORK, presented at 62nd Annual Meeting of the American-Society-of-Hematology (ASH), ELECTR NETWORK, 05 December 2020 - 08 December 2020, http://dx.doi.org/10.1182/blood-2020-139057

Barge L; Tran S; Kennedy GA; Ritchie D; Gottlieb D; Milliken S; Spencer A; Purtill D; Perera T; Doocey R; Larsen SR; Butler A; Bardy PG; Greenwood M; Durrant S; Curley C; Stewart C; Tam CS; Collins J; Bilmon I; Di Ciaccio PR; Patil SS; Han M-H; Hamad N, 2020, 'Improvement in Non-Relapse Mortality Following Allogeneic Transplantation for Chronic Lymphocytic Leukaemia in Australia and New Zealand: An Australasian Bone Marrow Transplant Recipient Registry Study', in BLOOD, ELSEVIER, ELECTR NETWORK, presented at 62nd Annual Meeting of the American-Society-of-Hematology (ASH), ELECTR NETWORK, 05 December 2020 - 08 December 2020, http://dx.doi.org/10.1182/blood-2020-136574

Sharplin KM; Ritchie D; Gottlieb D; Bilmon I; Panicker S; Kennedy GA; Curley C; Purtill D; Cooney J; Doocey R; Berkahn L; Milliken S; Di Ciaccio PR; Bardy PG; Spencer A; Curtis DJ; Patil SS; Larsen SR; Perera T; Butler A; Greenwood M; Watson A-M; Lai HC; Wong E; Tran S; Hamad N, 2020, 'An Australasian Bone Marrow Transplant Registry (ABMTR) Study of the Trends and Outcomes of Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) in Hodgkin Lymphoma between 2009-2019: Relapse Remains the Most Common Cause of Death Post Transplantation', in Blood, American Society of Hematology, pp. 36 - 37, http://dx.doi.org/10.1182/blood-2020-138684

Manos K; Lasica M; Grigg A; Di Ciaccio PR; Wong J; Sekaran UC; Wight J; Goh Z; Jina H; Butler L; Yannakou CK; Hamad N; Gregory GP; Gangatharan SA; Cochrane T; Piper K; Churilov L; Hawkes EA, 2020, 'Prolonged Lymphopenia and Infection Risk Is Mitigated By Antimicrobial Prophylaxis in Patients with Indolent Non-Hodgkin Lymphoma (iNHL) Treated with Bendamustine +/- Anti-CD20 Antibody: The Australasian Lymphoma Alliance Experience', in Blood, American Society of Hematology, pp. 47 - 49, http://dx.doi.org/10.1182/blood-2020-138642

Di Ciaccio PR; Polizzotto MN; Cwynarski K; Burton C; Jiamsakul A; Bower M; Kuruvilla J; Montoto S; McKay P; Osborne W; Milliken S; Linton K; Manos K; Kassam S; Doo NW; Watson A-M; Fedele PL; Yannakou CK; Hunt S; Renshaw H; Thakrar N; Smith A; Painter D; Maxwell A; Liu Q; Dhairyawan R; Ferguson G; Pickard K; Hamad N, 2020, 'Survival Outcomes for Plasmablastic Lymphoma: An International, Multicentre Study By the Australasian Lymphoma Alliance', in Blood, American Society of Hematology, pp. 1 - 2, http://dx.doi.org/10.1182/blood-2020-134972

Connolly L; Weickhardt A; Grimison P; Asher R; Hellier G; Lewin J; Liow E; Toner G; Tung I; Tran B; Hill S; Kuchel A; Walpole E; Mckenzie J; Goh J; Forgeson G; Tan A; Joshi A; Wickham A; Tan H; Wang Y; Winstanley M; Hamad N; Wong V, 2020, 'Outcomes of high dose chemotherapy and stem cell transplantation for relapsed or refractory germ cell tumours from 1999-2019. An Australia and New Zealand (ANZ). registry-based study in collaboration with ABMTRR.', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 45 - 45, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000594482700027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cashman H; Hamad N; Moore J; Milliken S; Lavee O; Withers B; Mayson E; Kliman D; Kesby J; Bell J; Vachalec S, 2019, 'An Electronic Health Record Facilitates a Safer and More Efficient Rural Outreach Haematology/Oncology Service', in BLOOD, ELSEVIER, FL, Orlando, presented at 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), FL, Orlando, 05 December 2019 - 10 December 2019, http://dx.doi.org/10.1182/blood-2019-127796

Hardefeldt P; Moore J; Milliken S; Fay K; Orly L; Mayson E; Withers B; Hamad N, 2019, 'Dose Adjusted R-EPOCH Does Not Improve Outcomes in High Grade B Cell Lymphoma with Double Expressor Status or Gain of MYC/BCL2', in Blood, American Society of Hematology, pp. 5336, http://dx.doi.org/10.1182/blood-2019-125154

Bishop M; Flinn I; Borchmann P; Jaeger U; Westin J; Hamad N; Purtill D; Greil R; Thomas S; Teshima T; Harigae H; Garcia C; Barba P; Deol A; Shaughnessy P; Gu J; Andreola G; Prieto MM; Pacaud L; Schuster S, 2019, 'BELINDA : A phase 3 study evaluating the safety and efficacy of tisagenlecleucel versus standard of care in adult patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma', in JOURNAL FOR IMMUNOTHERAPY OF CANCER, BMC, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000496473200822&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Talaulikar D; Cochrane T; Gibson J; Hamad N; Ho PJ; Issa S; Fiona K; Lim JH; Simpson D; Tam C; Castillo JJ, 2018, 'Bing Neel Syndrome: Retrospective Australasian Experience of a Rare Treatable Complication of Waldenstrom Macroglobulinaemia/ Lymphoplasmacytic Lymphoma', in BLOOD, ELSEVIER, CA, San Diego, presented at 60th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), CA, San Diego, 01 December 2018 - 04 December 2018, http://dx.doi.org/10.1182/blood-2018-99-113969

Maerevoet M; Vermaat J; Canales MA; Casasnovas R-O; Van Den Neste E; Goy A; Hill BT; Thieblemont C; De La Cruz MDF; Cavallo F; Follows G; Choquet S; Gurion R; Bouabdallah R; Jaeger U; Nagy A; Kuruvilla J; Warzocha K; Kalakonda N; Caimi P; Bakhshi S; Ku M; Hamad N; Veelken H; Matczak E; Ma X; Saint-Martin J-R; Shah JJ; Kauffman MG; Shacham S; Zijlstra JM, 2018, 'Single Agent Oral Selinexor Demonstrates Deep and Durable Responses in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in Both GCB and Non-GCB Subtypes: The Phase 2b Sadal Study', in Blood, American Society of Hematology, pp. 1677, http://dx.doi.org/10.1182/blood-2018-99-116868

Hamad N; Rahman SMM; Islam MS, 2017, 'Novel Remote Authentication Protocol Using Heart-signals with Chaos Cryptography', in 2017 INTERNATIONAL CONFERENCE ON INFORMATICS, HEALTH & TECHNOLOGY (ICIHT), IEEE, SAUDI ARABIA, Riyadh, presented at International Conference on Informatics, Health and Technology (ICIHT), SAUDI ARABIA, Riyadh, 21 February 2017 - 23 February 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000403395000024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page